Aerie Pharmaceuticals Stock Filter Stocks by Fundamentals
AERIDelisted Stock | USD 15.25 0.01 0.07% |
Aerie Pharmaceuticals fundamentals help investors to digest information that contributes to Aerie Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Aerie Stock. The fundamental analysis module provides a way to measure Aerie Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Aerie Pharmaceuticals stock.
Aerie |
Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
All Next | Launch Module |
Aerie Fundamentals
Return On Equity | -22.55 | |||
Return On Asset | -0.0459 | |||
Profit Margin | (0.17) % | |||
Operating Margin | (0.12) % | |||
Current Valuation | 918.14 M | |||
Shares Outstanding | 49.42 M | |||
Shares Owned By Insiders | 1.79 % | |||
Shares Owned By Institutions | 98.21 % | |||
Number Of Shares Shorted | 1.52 M | |||
Price To Earning | (19.00) X | |||
Price To Book | 34.26 X | |||
Price To Sales | 3.52 X | |||
Revenue | 194.13 M | |||
Gross Profit | 167.29 M | |||
EBITDA | (7.81 M) | |||
Net Income | (74.81 M) | |||
Cash And Equivalents | 184.37 M | |||
Cash Per Share | 3.73 X | |||
Total Debt | 234.53 M | |||
Debt To Equity | 9.41 % | |||
Current Ratio | 2.60 X | |||
Book Value Per Share | 0.51 X | |||
Cash Flow From Operations | (99.15 M) | |||
Short Ratio | 1.91 X | |||
Earnings Per Share | (1.47) X | |||
Target Price | 15.35 | |||
Number Of Employees | 376 | |||
Beta | -0.062 | |||
Market Capitalization | 753.62 M | |||
Total Asset | 431.39 M | |||
Retained Earnings | (919.58 M) | |||
Working Capital | 121.31 M | |||
Current Asset | 138.43 M | |||
Current Liabilities | 17.12 M | |||
Z Score | -4.8 | |||
Net Asset | 431.39 M |
About Aerie Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Aerie Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aerie Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aerie Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Aerie Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Aerie Pharmaceuticals' short interest history, or implied volatility extrapolated from Aerie Pharmaceuticals options trading.
Pair Trading with Aerie Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aerie Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerie Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Aerie Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aerie Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aerie Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aerie Pharmaceuticals to buy it.
The correlation of Aerie Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aerie Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aerie Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aerie Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Consideration for investing in Aerie Stock
If you are still planning to invest in Aerie Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aerie Pharmaceuticals' history and understand the potential risks before investing.
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |